Gross profit 94,309 91,490 83,320 10,989 13.2 Other income 2,454 2,858 1,453 1,001 68.9 Profit before expenses 96,763 94,348 84,773 11,990 14.1 Selling and distribution expenses 25,061 22,708 23,815 1,246
the management to cost of distribution and administrative expenses decreased from the change of strategy of the distribution channels in order to decrease cost and expenses from the past that the
E_1 Legal_FA_2015_12_29-c A WCorpL4.1hig A Executive Summary of Management Discussion and Analysis 1 For the Year Ending December 31, 2018 In 2018, the overall Thai economy maintained its growth due largely to healthier growth of exports and tourism, especially in the first half of the year. Meanwhile, the government continued to implement measures to promote and strengthen the domestic economy through support of investment and private spending as well as bolstering opportunities for other econo...
received 4,071 Lease liability payments 11,754 Dividend received 9 Dividend paid 20,219 Investments in JV & Other 252 Cash decrease 1,216 Total 97,835 97,835 8 FY20 MD&A Advanced Info Service Plc. 2021
received 220 Dividend paid 21,203 Sale of equipment 111 Lease liability payments 11,882 Dividend received 15 Repayment of ST & LT borrowings 18,785 Income tax paid 5,781 Finance cost paid 3,692 Investment in
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
purchasers generation and distribution. Mr. Khomwit Boomthamrongkit is also an executive and a shareholder in many companies such as SBP Timber Group Co., Ltd. having its main business of importing and
, operates the business of manufacturing and distribution of dialysis and medical equipment, later in February 2018, NCLpurchased some shares from a shareholder, making it the major shareholder with 52.80% of